Allianz Asset Management
ABMD

Allianz Asset Management’s Abiomed Inc ABMD Stock Holding History

Allianz Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,471
Closed -$529K – 2720
2021
Q4 		$529K Hold
1,471
– – ﹤0.01% 2173
2021
Q3 		$479K Buy
1,471
+78
+6% +$26.4K ﹤0.01% 2249
2021
Q2 		$435K Buy
+1,393
New +$427K ﹤0.01% 2102
2021
Q1 		– Sell
-2,798
Closed -$907K – 2335
2020
Q4 		$907K Buy
2,798
+2,059
+279% +$570K ﹤0.01% 1508
2020
Q3 		$205K Sell
739
-1,252
-63% -$361K ﹤0.01% 1785
2020
Q2 		$481K Sell
1,991
-589
-23% -$118K ﹤0.01% 2063
2020
Q1 		$375K Sell
2,580
-3,260
-56% -$541K ﹤0.01% 2160
2019
Q4 		$997K Sell
5,840
-4,090
-41% -$758K ﹤0.01% 2198
2019
Q3 		$1.77M Sell
9,930
-17,048
-63% -$3.69M ﹤0.01% 1880
2019
Q2 		$7.03M Sell
26,978
-6,669
-20% -$1.77M 0.01% 1346
2019
Q1 		$9.61M Sell
33,647
-47,769
-59% -$15.9M 0.01% 1167
2018
Q4 		$26.5M Buy
81,416
+6,214
+8% +$2.16M 0.03% 589
2018
Q3 		$33.8M Buy
75,202
+65,261
+656% +$25.7M 0.03% 592
2018
Q2 		$4.07M Sell
9,941
-5,057
-34% -$1.83M ﹤0.01% 1626
2018
Q1 		$4.36M Buy
14,998
+115
+0.8% +$29.1K ﹤0.01% 1591
2017
Q4 		$2.79M Buy
14,883
+1,152
+8% +$215K ﹤0.01% 1886
2017
Q3 		$2.31M Sell
13,731
-274
-2% -$41.4K ﹤0.01% 1960
2017
Q2 		$2.01M Sell
14,005
-188
-1% -$25.3K ﹤0.01% 1980
2017
Q1 		$1.78M Sell
14,193
-59,612
-81% -$6.91M ﹤0.01% 2043
2016
Q4 		$8.32M Sell
73,805
-29,401
-28% -$3.41M 0.01% 1440
2016
Q3 		$13.3M Sell
103,206
-10,982
-10% -$1.32M 0.01% 1189
2016
Q2 		$12.5M Buy
114,188
+15,623
+16% +$1.55M 0.01% 1132
2016
Q1 		$9.35M Buy
98,565
+62,860
+176% +$5.31M 0.01% 1155
2015
Q4 		$3.22M Buy
35,705
+13,585
+61% +$1.15M ﹤0.01% 1516
2015
Q3 		$2.05M Buy
22,120
+865
+4% +$76.2K ﹤0.01% 1595
2015
Q2 		$1.4M Buy
+21,255
New +$1.41M ﹤0.01% 1844

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Allianz Asset Management's ABMD Position: Q1 2022 in Review

Allianz Asset Management sold out of Abiomed Inc (ABMD) in Q1 2022, closing a stake of 1,471 shares — an estimated $529K sold.

Allianz Asset Management first reported a position in ABMD in Q2 2015 and held it in 26 quarters. The position peaked at $33.8M in Q3 2018. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

  • Allianz Asset Management reported no remaining Abiomed Inc position as of Q1 2022 after selling out during the quarter.
  • Allianz Asset Management sold 1,471 Abiomed Inc shares in Q1 2022, an estimated $529K.
  • Allianz Asset Management first reported a position in Abiomed Inc in Q2 2015 and held it in 26 quarters.
  • Allianz Asset Management's Abiomed Inc position peaked at $33.8M in Q3 2018.
  • 500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on Allianz Asset Management's 13F filing for Q1 2022, filed 13 May 2022.